TONIX Pharmaceuticals' Bedtime Very Low Dose Cyclobenzaprine Study Featured in Journal of Rheumatology - Drugs.com MedNews
Links shared publicly online about this topic.
- 15total visits
TONIX Pharmaceuticals' Bedtime Very Low Dose Cyclobenzaprine Study Featured in Journal of Rheumatology - Drugs.com MedNews
-Phase 2a Study Results Demonstrate Improvement in Core Fibromyalgia Symptoms Including Pain, Tenderness, Fatigue and Depression- -Correlation Between Improved
View full resource at drugs.com
Tags: Fibromyalgia, Drug, Pharma, Muscle Relaxer, Flexeril, Rheumatology
Most Recently Shared on September 7, 2011 at 2:04 pm By:
TONIX Pharmaceuticals' Bedtime Very Low Dose Cyclobenzaprine Study Featured in Journal of Rheumatology: -P... http://t.co/NzYE6ev #drug
TONIX Pharmaceuticals’ Bedtime Very Low Dose Cyclobenzaprine Study Featured in Journal of Rheumatology | Business Wire
businesswire.com — “TONIX Pharmaceuticals, Inc. a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system (“CN” View full resource at businesswire.com
Most Recently Shared on September 7, 2011 at 2:13 pm By:
TONIX Pharmaceuticals’ Bedtime Very Low Dose Cyclobenzaprine Study Featured in Journal of Rheumatology: NEW YORK... http://t.co/PW6ONYl
Advertisement
